WHO ICTRP trial
Study on the Effects of Papain and Alpha-Amylase Combination in Treating…
CTRI/2025/01/078902 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/01/078902 |
|---|---|
| Public title | Study on the Effects of Papain and Alpha-Amylase Combination in Treating Indigestion. |
| Scientific title | Fixed dose combination of papain and alpha-amylase in patients with functional dyspepsia â?? A real-world effectiveness study - NIL |
| Primary sponsor | Biological E Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: K929- Disease of digestive system, unspecified |
| Interventions | Intervention1: NIL: NIL Control Intervention1: NIL: NIL |
| Registration date | Jan 17, 2025 |
| Target size | 160 |
| Secondary IDs | BE/RWE-BZ/01/25 Version 1;NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: